Ryan Cohlhepp, President and COO at Bicara Therapeutics Inc. (BCAX), sold 77,400 shares at $18.06 ($1.4M) on 2025-10-07, disclosed to the SEC on 2025-10-08.
Scheduled sale ($1.4M) by President and COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.06 | 15,600 | $282K | 20.2% |
| 2 | $18.06 | 24,000 | $433K | 31.0% |
| 3 | $18.06 | 24,000 | $433K | 31.0% |
| 4 | $18.06 | 2,900 | $52K | 3.7% |
| 5 | $18.06 | 2,900 | $52K | 3.7% |
| 6 | $18.06 | 8,000 |
| $144K |
| 10.3% |
| Total | $18.06 avg | 77,400 | $1.4M | 100% |
| Filing → |
| BCAX | SELL | 2026-07-10 | $833K | — | Filing → |
| BCAX | SELL | 2026-05-18 | $254K | — | Filing → |
| BCAX | SELL | 2026-04-17 | $288K | — | Filing → |